Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
暂无分享，去创建一个
J. Hecht | R. Salazar | E. Van Cutsem | J. Tabernero | M. Makrutzki | S. Clarke | M. Moore | G. Bodoky | D. Cunningham | S. Im | P. Hoff | F. Rivera | A. de Gramont | T. Cartwright | H. Schmoll | T. André | E. Bajetta | F. Maindrault-Goebel | A. Shang | E. Shacham‐Shmueli | E. Shacham-Shmueli